Junjian Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Junjian Huang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Andrew J. Gunn
Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama
4 shared publicationsHusamuddin El Khudari
Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama
3 shared publicationsKevin Delijani
Georgetown Medical School, Washington, District of Columbia
3 shared publications- Andrew J. Gunn
University of Kentucky College of Medicine, Lexington, USA
2 shared publications - Cody H. Savage
Division of Vascular and Interventional Radiology, Department of Radiology, University of Alabama at Birmingham, Birmingham, USA
2 shared publications Jesse Jones
Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama
2 shared publications
Latest Publications
- 3 May 2024
- Published by Springer Nature
- p. 605-620
Pain Interventions
- 27 December 2023
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (3) , 919-926
Percutaneous cryoablation of 100 anterior renal tumors: safety and technical success
Purpose To assess the safety, technical success, and clinical outcomes of percutaneous cryoablation (PCA) in patients with anterior renal tumors. Methods A retrospective analysis of patients with anterior renal tumors, defined as tumors at or anterior to the level of the renal pelvis, treated with CT-guided PCA from 2008 to 2022. Summary statistics included demographics and baseline tumor attributes. Treatment and follow-up metrics included primary and secondary technical success, adverse events (AEs) according to the SIR classification, local recurrence, overall survival (OS), and cancer-specific survival (CSS)). 100 patients (60 males; mean age: 63, mean BMI: 33, mean Charlson comorbidity index:6) with 100 anterior renal tumors were included. Results 78% of tumors were T1a and 22% T1b with mean maximal tumoral dimension of 29 mm (range: 6–62 mm) and mean distance to nearest critical structure 9 mm (range: 0–40 mm). Mean follow-up was 20.9 months (range: 3–103). 28% of PCAs required hydrodissection. Technical success was achieved in 92% of patients; with six remaining patients undergoing successful repeat PCA (secondary technical success: 98%). The remaining two patients without primary technical success were either surveilled or had a benign pathology on resulted concomitant biopsy. Four patients (4%) had major AEs (hemorrhage requiring prolonged admission, transfusion, or embolization (n = 3), perinephric abscess requiring drainage (n = 1)) and 27% had minor AEs. Eight patients (8%) had recurrence with a one-year OS of 94% and CSS of 100%. All recurrences underwent repeat ablation without additional recurrence and 3/8 (38%) were T1b and 5/8 (63%) were T1a tumors. Conclusion PCA of anterior renal tumors can be performed safely with high rates of technical and oncologic success.
- 27 December 2023
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (3) , 919-926
Percutaneous cryoablation of 100 anterior renal tumors: safety and technical success
Purpose To assess the safety, technical success, and clinical outcomes of percutaneous cryoablation (PCA) in patients with anterior renal tumors. Methods A retrospective analysis of patients with anterior renal tumors, defined as tumors at or anterior to the level of the renal pelvis, treated with CT-guided PCA from 2008 to 2022. Summary statistics included demographics and baseline tumor attributes. Treatment and follow-up metrics included primary and secondary technical success, adverse events (AEs) according to the SIR classification, local recurrence, overall survival (OS), and cancer-specific survival (CSS)). 100 patients (60 males; mean age: 63, mean BMI: 33, mean Charlson comorbidity index:6) with 100 anterior renal tumors were included. Results 78% of tumors were T1a and 22% T1b with mean maximal tumoral dimension of 29 mm (range: 6–62 mm) and mean distance to nearest critical structure 9 mm (range: 0–40 mm). Mean follow-up was 20.9 months (range: 3–103). 28% of PCAs required hydrodissection. Technical success was achieved in 92% of patients; with six remaining patients undergoing successful repeat PCA (secondary technical success: 98%). The remaining two patients without primary technical success were either surveilled or had a benign pathology on resulted concomitant biopsy. Four patients (4%) had major AEs (hemorrhage requiring prolonged admission, transfusion, or embolization (n = 3), perinephric abscess requiring drainage (n = 1)) and 27% had minor AEs. Eight patients (8%) had recurrence with a one-year OS of 94% and CSS of 100%. All recurrences underwent repeat ablation without additional recurrence and 3/8 (38%) were T1b and 5/8 (63%) were T1a tumors. Conclusion PCA of anterior renal tumors can be performed safely with high rates of technical and oncologic success.
- Open Access
- 22 May 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (8) , 2558-2561
Case report of a giant cell tumor of the carotid sheath
- 22 May 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (8) , 2558-2561
Open AccessCase report of a giant cell tumor of the carotid sheath
- 11 May 2023
- Published by Elsevier in Clinical Imaging
- Vol. 100, 30-35
Limited ability of the renal ablation-specific (MC)2 risk scoring system to predict major adverse events from percutaneous renal microwave ablation
- 11 May 2023
- Published by Elsevier in Clinical Imaging
- Vol. 100, 30-35
Limited ability of the renal ablation-specific (MC)2 risk scoring system to predict major adverse events from percutaneous renal microwave ablation
- 10 March 2023
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 46 (11) , 1538-1550
Image-Guided Radiofrequency Ablation for Joint and Back Pain: Rationales, Techniques, and Results
Image-guided minimally invasive radiofrequency ablation (RFA) of sensory nerves has emerged as a treatment option for pain and swelling associated with advanced symptomatic joint and spine degeneration to bridge the gap between optimal medical therapy and surgical treatments. RFA of articular sensory nerves and the basivertebral nerve use image-guided percutaneous approaches resulting in faster recovery time and minimal risks. The current published evidence indicates clinical effectiveness; however, further research must be performed comparing other conservative treatments with RFA to understand further its role in different clinical settings, such as osteonecrosis. This review article discusses and illustrates the applications of RFA for treating symptomatic joint and spine degeneration.
- 10 March 2023
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 46 (11) , 1538-1550
Image-Guided Radiofrequency Ablation for Joint and Back Pain: Rationales, Techniques, and Results
Image-guided minimally invasive radiofrequency ablation (RFA) of sensory nerves has emerged as a treatment option for pain and swelling associated with advanced symptomatic joint and spine degeneration to bridge the gap between optimal medical therapy and surgical treatments. RFA of articular sensory nerves and the basivertebral nerve use image-guided percutaneous approaches resulting in faster recovery time and minimal risks. The current published evidence indicates clinical effectiveness; however, further research must be performed comparing other conservative treatments with RFA to understand further its role in different clinical settings, such as osteonecrosis. This review article discusses and illustrates the applications of RFA for treating symptomatic joint and spine degeneration.
- 1 September 2022
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 39 (02) , e1
Basivertebral Nerve Ablation
The publisher needs to correct Dr. Joshua A. Hirsch's name in the above article in Seminars in Interventional Radiology, Volume 39, Number 2, 2022. The corrected name is indicated above within the byline. Article published online: 01 September 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 1 September 2022
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 39 (02) , e1
Basivertebral Nerve Ablation
The publisher needs to correct Dr. Joshua A. Hirsch's name in the above article in Seminars in Interventional Radiology, Volume 39, Number 2, 2022. The corrected name is indicated above within the byline. Article published online: 01 September 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 1 August 2022
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 39 (04) , 421-427
Antibiotics Tubes and Lines
Antibiotic prophylaxis in interventional radiology (IR) is widely used; however, such practice is based on data from the surgical literature. Although published guidelines can help determine the need for prophylactic antibiotic use in the patient undergoing percutaneous procedures, local practice patterns often dictate when such medications are given. In this article, the current state of periprocedural antibiotic use in commonly performed IR procedures (i.e., tube and catheter placements) is presented. Article published online: 17 November 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 1 August 2022
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 39 (04) , 421-427
Antibiotics Tubes and Lines
Antibiotic prophylaxis in interventional radiology (IR) is widely used; however, such practice is based on data from the surgical literature. Although published guidelines can help determine the need for prophylactic antibiotic use in the patient undergoing percutaneous procedures, local practice patterns often dictate when such medications are given. In this article, the current state of periprocedural antibiotic use in commonly performed IR procedures (i.e., tube and catheter placements) is presented. Article published online: 17 November 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 1 April 2022
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 39 (02) , 167-171
Intercostal Cryoneurolysis
Chest wall pain affects many patients following chest surgery, fractures, or malignancies, and can be very difficult to manage with normal pharmacologic agents. Intercostal ablation provides one alternative treatment modality for patients suffering from intercostal pain. Intercostal cryoneurolysis involves using extreme cold to cause Wallerian degeneration of the targeted intercostal nerve. This article reviews the patient selection, technique, and complications in the utilization of intercostal neurolysis in the treatment of intractable chest pain.
- 1 April 2022
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 39 (02) , 167-171
Intercostal Cryoneurolysis
Chest wall pain affects many patients following chest surgery, fractures, or malignancies, and can be very difficult to manage with normal pharmacologic agents. Intercostal ablation provides one alternative treatment modality for patients suffering from intercostal pain. Intercostal cryoneurolysis involves using extreme cold to cause Wallerian degeneration of the targeted intercostal nerve. This article reviews the patient selection, technique, and complications in the utilization of intercostal neurolysis in the treatment of intractable chest pain.
- 1 April 2022
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 39 (02) , 162-166
Basivertebral Nerve Ablation
Low back pain is one of the most prevalent musculoskeletal ailments in the United States. Intraosseous radiofrequency ablation of the basivertebral nerve is an effective and durable therapy for low back pain and can be offered to patients who have chronic low back pain of greater than 6 months of duration, failure to respond to noninvasive therapies for 6 months, with either Modic Type I or Type II changes at L3–S1. This article reviews the anatomy and physiology, patient selection, technique, and evidence regarding basivertebral nerve ablation.
- 1 April 2022
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 39 (02) , 162-166
Basivertebral Nerve Ablation
Low back pain is one of the most prevalent musculoskeletal ailments in the United States. Intraosseous radiofrequency ablation of the basivertebral nerve is an effective and durable therapy for low back pain and can be offered to patients who have chronic low back pain of greater than 6 months of duration, failure to respond to noninvasive therapies for 6 months, with either Modic Type I or Type II changes at L3–S1. This article reviews the anatomy and physiology, patient selection, technique, and evidence regarding basivertebral nerve ablation.